China plans to set up a state catalog for medicines in short supply to strengthen early warning on medicine shortage and ensure drug supply, according to a draft government regulation.
Xu Jinghe, deputy commissioner of China's National Medical Products Administration (NMPA), met with a delegation led by Yasuhiro Fujiwara, chief executive of Japan's Pharmaceuticals and Medical Devices Agency (PMDA) on Jan 7, 2020.
The National Medical Products Administration (NMPA) has given the go-ahead for the launch of China's first self-developed 13-valent pneumonia vaccine to better protect babies from a leading cause of death.
- Release of Annual Report for National Medical Device Adverse Event Monitoring (2018)
- NMPA Issued Four Guidelines for Technical Review of the Registration of Assay Reagents for Aspartate Aminotransferase and Others
- NMPA Issued Three Guidelines for Technical Review of the Registration of Embryo Replacement Catheter in Assisted Reproduction and Others